BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Hemera Biosciences Inc.

Headquarters: Waltham, MA, United States
Year Founded: 2010
Status: Private

BioCentury | Jan 5, 2023
Management Tracks

Sanofi’s Sarchi heads to Replimune

Plus: Albers joins Atlas, new CBO at Altimmune and updates from Nuvig, Zymeworks, Fulcrum, Step, Charm, Kymera and more
BioCentury | Oct 3, 2022
Product Development

Janssen’s first AAV programs remain in play with AAO readouts

Data for X-linked retinitis pigmentosa, geographic atrophy support moving into later-stage trials
BioCentury | Jun 27, 2019
Product Development

Gene therapy’s next frontier lies beyond rare, monogenic diseases

How gene therapy is transitioning from single gene disorders to a modality of general use
BioCentury | Feb 22, 2019
Emerging Company Profile

Gyroscope complements dry AMD

Gyroscope's one-shot dry AMD therapy supplies an upstream complement factor
BioCentury | Oct 21, 2013
Emerging Company Profile

Hemera: Special sauce in AMD

Hemera attacks MAC to treat wet and dry AMD
Items per page:
1 - 5 of 5